CY2028A - Peptides having a brady kinine-inhibiting activity - Google Patents

Peptides having a brady kinine-inhibiting activity

Info

Publication number
CY2028A
CY2028A CY202898A CY202898A CY2028A CY 2028 A CY2028 A CY 2028A CY 202898 A CY202898 A CY 202898A CY 202898 A CY202898 A CY 202898A CY 2028 A CY2028 A CY 2028A
Authority
CY
Cyprus
Prior art keywords
amino acid
peptides
bradykinin
direct bond
optionally
Prior art date
Application number
CY202898A
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CY2028A publication Critical patent/CY2028A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aromatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5 and K is a radical -NH(CH2)-1-4-CO- or is a direct bond, have bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are promoted, induced or sustained by bradykinin and bradykinin- related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
CY202898A 1988-11-24 1998-02-20 Peptides having a brady kinine-inhibiting activity CY2028A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3839581 1988-11-24
DE3916291 1989-05-19
DE3918225 1989-06-03

Publications (1)

Publication Number Publication Date
CY2028A true CY2028A (en) 1998-02-20

Family

ID=27198531

Family Applications (2)

Application Number Title Priority Date Filing Date
CY202898A CY2028A (en) 1988-11-24 1998-02-20 Peptides having a brady kinine-inhibiting activity
CY200800022C CY2008022I1 (en) 1988-11-24 2008-12-30 PEPTIDES HAVING A BRADY KININE-INHIBITING ACTIVITY

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY200800022C CY2008022I1 (en) 1988-11-24 2008-12-30 PEPTIDES HAVING A BRADY KININE-INHIBITING ACTIVITY

Country Status (26)

Country Link
EP (1) EP0370453B1 (en)
JP (1) JPH07121956B2 (en)
KR (1) KR0139632B1 (en)
CN (1) CN1035006C (en)
AT (1) ATE107318T1 (en)
AU (1) AU612054B2 (en)
CA (1) CA1340667C (en)
CY (2) CY2028A (en)
CZ (1) CZ282384B6 (en)
DE (3) DE122008000066I2 (en)
DK (1) DK175344B1 (en)
ES (1) ES2057071T3 (en)
FI (1) FI94353C (en)
HK (1) HK1006716A1 (en)
HU (2) HU210566B (en)
IE (1) IE63490B1 (en)
IL (1) IL91298A (en)
LU (1) LU91499I2 (en)
LV (1) LV10720B (en)
MX (1) MX9203277A (en)
NL (1) NL300359I2 (en)
NO (2) NO177597C (en)
NZ (1) NZ230244A (en)
PH (1) PH31009A (en)
PT (1) PT91692B (en)
SK (1) SK279315B6 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013270A1 (en) * 1990-04-26 1991-10-31 Hoechst Ag PEPTIDES WITH BRADYKININ ANTAGONISTIC EFFECT
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
EP0502987B1 (en) * 1989-12-08 1994-08-31 Trustees Of Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
US5843900A (en) * 1991-04-01 1998-12-01 Cortech, Inc. Bradykinin antagonists
US6770741B1 (en) 1991-04-19 2004-08-03 Scios Inc. Bradykinin antagonist peptides
CA2106762C (en) * 1991-04-19 2000-10-10 Donald J. Kyle Bradykinin antagonist peptides
EP0618809B1 (en) * 1991-04-19 1998-08-19 Scios Nova Inc. Bradykinin type peptides
HUT63060A (en) * 1991-08-22 1993-07-28 Hoechst Ag Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW199863B (en) * 1991-12-21 1993-02-11 Hoechst Ag
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
TW258739B (en) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (en) * 1992-06-18 1994-08-19 Adir New peptide derivatives with bradykinin antagonist activity, their preparation process and the pharmaceutical compositions containing them.
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (en) * 1993-12-31 1995-07-13 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of viral diseases
CA2184824A1 (en) * 1994-03-09 1995-09-14 Val S. Goodfellow Bradykinin antagonist peptides incorporating n-substituted glycines
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
AU6044496A (en) * 1995-06-05 1996-12-24 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
FR2737408B1 (en) * 1995-07-31 1997-09-05 Oreal USE OF A BRADYKININE ANTAGONIST IN A COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION AND COMPOSITION OBTAINED
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
US5834431A (en) * 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
FR2739553B1 (en) 1995-10-06 1998-01-02 Oreal USE OF BRADYKININE ANTAGONISTS TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE HAIR LOSS
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
DE19612067A1 (en) * 1996-03-27 1997-10-02 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of chronic fibrogenetic liver diseases and acute liver diseases
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
DE19642289A1 (en) 1996-10-14 1998-04-16 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment and prevention of Alzheimer's disease
DE10304994A1 (en) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
CN102532267B (en) * 2012-02-09 2014-06-18 深圳翰宇药业股份有限公司 Method for preparing icatibant
CN104043101B (en) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 A kind of icatibant composition for injection and preparation method thereof and preparation
KR102099509B1 (en) 2018-07-27 2020-04-09 강경순 Supports for fruit trees
CN111944016B (en) * 2020-08-25 2022-04-29 台州吉诺生物科技有限公司 Preparation method of icatibant acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044236A1 (en) * 1980-11-25 1982-06-16 Hoechst Ag, 6000 Frankfurt AMINO ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
DE3227055A1 (en) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt NEW DERIVATIVES OF 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THE USE THEREOF, AND 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID AS ANSWER FOR THEIR PRODUCTION
FR2575753B1 (en) * 1985-01-07 1987-02-20 Adir NOVEL PEPTIDE DERIVATIVES WITH NITROGEN POLYCYCLIC STRUCTURE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides

Also Published As

Publication number Publication date
CY2008022I2 (en) 2009-11-04
FI94353B (en) 1995-05-15
NL300359I1 (en) 2008-11-03
DE122008000066I2 (en) 2009-11-05
CY2008022I1 (en) 2009-11-04
PH31009A (en) 1997-12-23
MX9203277A (en) 1992-07-01
EP0370453B1 (en) 1994-06-15
ES2057071T3 (en) 1994-10-16
FI94353C (en) 1995-08-25
CN1042918A (en) 1990-06-13
EP0370453A2 (en) 1990-05-30
HK1006716A1 (en) 1999-03-12
NL300359I2 (en) 2009-02-02
DE122008000066I1 (en) 2009-05-20
IE63490B1 (en) 1995-05-03
PT91692B (en) 1995-05-31
PT91692A (en) 1990-03-30
CN1035006C (en) 1997-05-28
NO2008016I1 (en) 2008-11-17
SK490689A3 (en) 1998-09-09
CA1340667C (en) 1999-07-20
NO177597B (en) 1995-07-10
KR0139632B1 (en) 1998-07-01
HUT52527A (en) 1990-07-28
CZ490689A3 (en) 1997-03-12
ATE107318T1 (en) 1994-07-15
NO2008016I2 (en) 2012-10-01
IL91298A (en) 1994-05-30
NZ230244A (en) 1992-06-25
AU3943189A (en) 1990-05-31
DE3938751A1 (en) 1990-05-31
JPH07121956B2 (en) 1995-12-25
NO893193D0 (en) 1989-08-08
FI893738A0 (en) 1989-08-08
EP0370453A3 (en) 1991-12-04
NO893193L (en) 1990-05-25
LV10720B (en) 1996-02-20
IL91298A0 (en) 1990-03-19
IE892522L (en) 1990-05-24
HU210566B (en) 1995-05-29
CZ282384B6 (en) 1997-07-16
AU612054B2 (en) 1991-06-27
SK279315B6 (en) 1998-09-09
DE58907889D1 (en) 1994-07-21
FI893738A (en) 1990-05-25
DK384089D0 (en) 1989-08-04
KR900007870A (en) 1990-06-02
LU91499I2 (en) 2009-01-19
JPH02184697A (en) 1990-07-19
NO177597C (en) 1995-10-18
DK175344B1 (en) 2004-08-30
HU210712A9 (en) 1995-06-28
DK384089A (en) 1990-05-25
LV10720A (en) 1995-06-20

Similar Documents

Publication Publication Date Title
CY2028A (en) Peptides having a brady kinine-inhibiting activity
CY2029A (en) Peptide antagonists of bradykinin
LV10290A (en) Peptide with bradkinin antagonist activity